Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome

Arch Physiol Biochem. 2012 Jul;118(3):135-8. doi: 10.3109/13813455.2012.654800. Epub 2012 Feb 15.

Abstract

To allow early detection and prevention of metabolic disorders, circulating levels of adipokines involved in insulin sensitivity were compared with the hyperinsulinemic-euglycemic clamp. Twenty non-obese normo-glycaemic men (age 32.1 ± 6 years) underwent a clamp procedure. Levels of leptin, adiponectin, resistin, visfatin, omentin and chemerin levels were determined in fasting blood samples. Pearson correlation coefficients between the M-value for insulin sensitivity and fasting levels of chemerin (r = -0.63, P = 0.003) and leptin (r = -0.54, P = 0.013) performed better than conventional surrogate measures of insulin sensitivity (HOMA-IR: r = -0.45, P = 0.048; Quicki: r = 0.36, P = 0.12). However, only the relation between M-value(LBM) and chemerin remained significant when adjusting for BMI and fasting insulin levels (r = -0.559, P = 0.016). In conclusion, fasting levels of chemerin might be used as biomarker to identify insulin resistance in healthy men without typical characteristics of metabolic disorders.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / blood
  • Adult
  • Biomarkers / blood
  • Blood Glucose / analysis
  • Body Mass Index
  • Chemokines / blood*
  • Fasting
  • Glucose / administration & dosage
  • Glucose Clamp Technique
  • Humans
  • Insulin / blood
  • Insulin / pharmacology*
  • Insulin Resistance*
  • Intercellular Signaling Peptides and Proteins
  • Male

Substances

  • Adipokines
  • Biomarkers
  • Blood Glucose
  • Chemokines
  • Insulin
  • Intercellular Signaling Peptides and Proteins
  • RARRES2 protein, human
  • Glucose